文献速递神经肌肉病

肌萎缩侧索硬化基因检测实践调查

Genetic testing in ALS: A survey of current practices.
PubMed 文献 · Neurology · 2017-02-03

该研究通过在线问卷调查全球21国167名临床医生对肌萎缩侧索硬化(ALS)基因检测的态度与实践。多数受访者认为家族性ALS缺乏共识定义,90.2%对自认家族性ALS患者提供检测,49.4%对散发性ALS患者提供检测,实践差异与地域及专科经验相关。

要点

  • 多数医生认为家族性ALS缺乏共识定义
  • 90.2%的医生对家族性ALS患者提供基因检测

核心结论

  • 临床医生对家族性ALS定义缺乏共识,基因检测态度与实践存在显著差异。

研究设计与样本

  • 全球性在线问卷调查,分析来自21个国家167名临床医生的回复。

主要发现

  • 73.3%的受访者认为家族性ALS缺乏共识定义。
  • 90.2%的受访者对自认家族性ALS患者提供基因检测,49.4%对散发性ALS患者提供检测。
  • 常见检测基因包括SOD1、C9orf72、TARDBP和FUS。

临床怎么用

  • 临床医生应关注家族性ALS定义缺乏共识的现状,基因检测决策需结合家族史与基因突变信息。

局限性

  • 研究为问卷调查,未报告样本代表性及应答率等局限性信息。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To determine the degree of consensus among clinicians on the clinical use of genetic testing in amyotrophic lateral sclerosis (ALS) and the factors that determine decision-making. METHODS: ALS researchers worldwide were invited to participate in a detailed online survey to determine their attitudes and practices relating to genetic testing. RESULTS: Responses from 167 clinicians from 21 different countries were analyzed. The majority of respondents (73.3%) do not consider that there is a consensus definition of familial ALS (FALS). Fifty-seven percent consider a family history of frontotemporal dementia and 48.5% the presence of a known ALS genetic mutation as sufficient for a diagnosis of FALS. Most respondents (90.2%) offer genetic testing to patients they define as having FALS and 49.4% to patients with sporadic ALS. Four main genes (SOD1, C9orf72, TARDBP, and FUS) are commonly tested. A total of 55.2% of respondents would seek genetic testing if they had personally received a diagnosis of ALS. Forty-two percent never offer presymptomatic testing to family members of patients with FALS. Responses varied between ALS specialists and nonspecialists and based on the number of new patients seen per year. CONCLUSIONS: There is a lack of consensus among clinicians as to the definition of FALS. Substantial variation exists in attitude and practices related to genetic testing of patients and presymptomatic testing of their relatives across geographic regions and between experienced specialists in ALS and nonspecialists.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Vajda A, McLaughlin RL, Heverin M, et al. Genetic testing in ALS: A survey of current practices. Neurology. 2017. PMID: 28159885. doi:10.1212/WNL.0000000000003686

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。